| Literature DB >> 24661349 |
Maud Parise1, Tadeu Takao Almodovar Kubo, Thomas Martin Doring, Gustavo Tukamoto, Maurice Vincent, Emerson Leandro Gasparetto.
Abstract
BACKGROUND: Chronic pain disorders are presumed to induce changes in brain grey and white matters. Few studies have focused CNS alterations in trigeminal neuralgia (TN).Entities:
Mesh:
Year: 2014 PMID: 24661349 PMCID: PMC3997919 DOI: 10.1186/1129-2377-15-17
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Characteristics of TN patients
| 1 | M | 65 | 2 | V2 | R | 1200 |
| 2 | F | 65 | 5 | V2 + V1 | L | 200 |
| 3 | F | 40 | 4 | V2 | R | 1000 |
| 4 | F | 62 | 8 | V2 + V3 | L | 400 |
| 5 | F | 65 | 9 | V2 + V3 | L | 800 |
| 5 | F | 53 | 4 | V2 + V3 | R | 200 |
| 7 | F | 64 | 10 | V3 | L | 800 |
| 8 | F | 62 | 5 | V2 | L | 800 |
| 9 | F | 52 | 12 | V3 | R | 1000 |
| 10 | M | 54 | 4 | V2 | R | 400 |
| 11 | F | 57 | 11 | V2 + V3 | L | 1800 |
| 12 | F | 48 | 5 | V2 | R | 0 |
| 13 | F | 62 | 10 | V2 | R | 800 |
| 14 | F | 53 | 10 | V2 + V3 | R | 800 |
| 15 | F | 53 | 1 | V3 | L | 0 |
| 16 | M | 49 | 9 | V2 | R | 1800 |
| 17 | F | 62 | 17 | V2 + V3 | L | 800 |
| 18 | M | 40 | 5 | V3 | L | 800 |
| 19 | M | 53 | 6 | V2 + V3 | R | 1200 |
| 20 | M | 37 | 5 | V2 | L | 400 |
| 21 | F | 56 | 12 | V2 + V3 | L | 800 |
| 22 | F | 67 | 6 | V2 | L | 600 |
| 23 | F | 61 | 1 | V2 | R | 200 |
| 24 | F | 61 | 10 | V2 | L | 1200 |
TN = trigeminal neuralgia; F = female; M = male; R = right; L = left; V1 = ophthalmic branch; V2 = maxillary branch; V3 = mandibular branch; CBZ = carbamazepine.
Figure 1Perception (A) and pain threshold (B) in patients with TN. There was no difference between the affected side and the unaffected side. Differences in perception (C) and pain (D) threshold, between TN patients and controls. Patient’s pain threshold was significantly higher than controls (p < 0.001).
Figure 2Group differences in cortical thickness between TN patients and controls. Blue regions indicate areas showing thickness reduction and red regions indicate thickness increase in TN patients when compared to controls at a threshold p < 0,01, uncorrected. It was observed cortical thickness changes in areas that include orbitofrontal cortex, insula, motor cortex, anterior cingulate gyrus and temporal lobe. All these regions, involved in supraspinal nociceptive processing, show grey matter alterations in different types of chronic pain.
Figure 3Group differences in cortical thickness between patients and controls after correction for multiple comparisons. The inferior temporal gyrus (fusiform cortex) and cuneus/pre-cuneus showed significant thickness reduction (blue areas) in TN patients. The thickness reduction of fusiform cortex was negatively correlated to carbamazepine doses (p = 0.023 rho 1.000 -0.463).